Keywords

#saxagliptin

Saxagliptin

Chemical compound

Saxagliptin, sold under the brand name Onglyza, is an oral hypoglycemic of the dipeptidyl peptidase-4 (DPP-4) inhibitor class. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug.

Fri 5th

Provided by Wikipedia

Learn More

This keyword could refer to multiple things. Here are some suggestions:

Saxagliptin Dapagliflozin Metformin Dapagliflozin/saxagliptin Dipeptidyl peptidase-4 inhibitor Dapagliflozin/saxagliptin/metformin ATC code A10 Diabetes medication Alogliptin Discovery and development of dipeptidyl peptidase-4 inhibitors
0 searches
This keyword has never been searched before
This keyword has never been searched for with any other keyword.